Skip to content
★ Sign in to follow
董

董凡

Directeur
健帆生物
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€13.5M
▼ Sales (0 ops.)
—

Latest filing published 09 Mar 2022 for 健帆生物, €5.2M.

Filing timeline

BuySale
董凡

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2
Positive at T+90
50%
Median T+90
-1.0%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 09 Mar 2022 · 1707 days ago · €5.2M
    -28.2%
    Entry CN¥43.20 · Close at T+365 CN¥31.00
  • Filed 20 Jan 2022 · 1755 days ago · €8.3M
    -30.8%
    Entry CN¥49.66 · Close at T+365 CN¥34.35

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

董凡: trading record in brief

董凡 is a declared insider of 健帆生物 (senior executive), with filings sourced from SSE / SZSE (CSRC). The record holds 2 filings, for trades running from 20 January 2022 to 9 March 2022.

The open-market record is one-sided, with 2 purchases worth €13.5M and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

The latest filing, published on 9 March 2022, reports an open-market purchase of €5.2M in 健帆生物. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to 董凡

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    董事Executives健帆生物
    36M CNY11SZSE
    843,200 shares38.3% of flowA股XSHESZSE:173000005358173860
    Canonical exit: 7 Jun 2022 (T+90)
  • ▲
    董事Executives健帆生物
    60M CNY13SZSE
    1,184,700 shares61.7% of flowA股XSHESZSE:173000005235904960
    Canonical exit: 20 Apr 2022 (T+90)

2 of 2 declarations